---
name: half_life_obach
description: |-
    Half life of a drug is the duration for the concentration of the drug
    in the body to be reduced by half. It measures the duration of actions of a drug.
    This dataset deposited version under CHEMBL assay 1614674.
targets:
    - id: half_life_duration
      description: the time it takes for the plasma concentration of a drug in the body to be reduced by half
      units: hours
      type: continuous
      names:
          - drug half life time
          - the duration by which the concentration of the drug in the body is reduced by half
          - half life
      uris:
          - http://purl.bioontology.org/ontology/MESH/D006207
benchmarks:
    - name: TDC
      link: https://tdcommons.ai/
      split_column: split
identifiers:
    - id: SMILES
      type: SMILES
      description: SMILES
    - id: chembl_id
      type: Other
      names:
          - ChEMBL database id
          - ChEMBL identifier number
      description: ChEMBL ids
license: CC BY 4.0
links:
    - url: https://doi.org/10.1124/dmd.108.020479
      description: corresponding publication
    - url: https://tdcommons.ai/single_pred_tasks/adme/#half-life-obach-et-al
      description: data source
num_points: 667
bibtex:
    - |-
      @article{Obach2008,
      doi = {10.1124/dmd.108.020479},
      url = {https://doi.org/10.1124/dmd.108.020479},
      year = {2008},
      month = apr,
      publisher = {American Society for Pharmacology and Experimental Therapeutics (ASPET)},
      volume = {36},
      number = {7},
      pages = {1385--1405},
      author = {R. Scott Obach and Franco Lombardo and Nigel J. Waters},
      title = {Trend Analysis of a Database of Intravenous Pharmacokinetic
      Parameters in Humans for 670 Drug Compounds},
      journal = {Drug Metabolism and Disposition}
